{"canonical":"https://abierto.us/vendors/revagenix-inc-d98qfzupfxj9","key":"D98QFZUPFXJ9","name":"REVAGENIX INC","uei":"D98QFZUPFXJ9","city":"SAN MATEO","state":"CA","awards":2,"obligated":"14902708.61","notices_won":0,"top_agency_name":"National Institutes of Health","top_naics":"541715","cage":"8B1Y9","parent_name":"REVAGENIX INC","also_known_as":[],"country":"USA","actions":11,"first_action":"2025-04-22","last_action":"2026-07-10","breakdowns":{"naics":[{"key":"541715","name":null,"awards":2,"obligated":"14902708.61"}],"places":[{"key":"CA","name":null,"awards":2,"obligated":"14902708.61"}],"agencies":[{"key":"7529","name":"National Institutes of Health","awards":2,"obligated":"14902708.61"}],"award_types":[{"key":"DEFINITIVE CONTRACT","name":null,"awards":2,"obligated":"14902708.61"}],"competition":[{"key":"FULL AND OPEN COMPETITION","name":null,"awards":2,"obligated":"14902708.61"}],"product_service_codes":[{"key":"AN12","name":null,"awards":2,"obligated":"14902708.61"}]},"awards_list":[{"award_key":"CONT_AWD_75N93022C00061_7529_-NONE-_-NONE-","permalink":"https://www.usaspending.gov/award/CONT_AWD_75N93022C00061_7529_-NONE-_-NONE-/","piid":"75N93022C00061","parent_piid":null,"award_type":"DEFINITIVE CONTRACT","vendor_key":"D98QFZUPFXJ9","recipient_name":"REVAGENIX INC","recipient_uei":"D98QFZUPFXJ9","recipient_cage":"8B1Y9","recipient_city":"SAN MATEO","recipient_state":"CA","sub_name":"National Institutes of Health","office_name":"NATIONAL INSTITUTES OF HEALTH NIAID","office_key":"o-75N930","first_action_date":"2025-04-28","last_action_date":"2026-07-10","actions":6,"obligated":"12097666.00","current_total_value":"28167401.00","potential_total_value":"28167401.00","naics":"541715","psc":"AN12","extent_competed":"FULL AND OPEN COMPETITION","set_aside":"NO SET ASIDE USED.","offers_received":30,"description":"A NOVEL LPXC INHIBITOR WITH PAN-RESISTANT PSEUDOMONAS AND BURKHOLDERIA ACTIVITY.","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null},{"award_key":"CONT_AWD_75N93020C00018_7529_-NONE-_-NONE-","permalink":"https://www.usaspending.gov/award/CONT_AWD_75N93020C00018_7529_-NONE-_-NONE-/","piid":"75N93020C00018","parent_piid":null,"award_type":"DEFINITIVE CONTRACT","vendor_key":"D98QFZUPFXJ9","recipient_name":"REVAGENIX INC","recipient_uei":"D98QFZUPFXJ9","recipient_cage":"8B1Y9","recipient_city":"SAN MATEO","recipient_state":"CA","sub_name":"National Institutes of Health","office_name":"NATIONAL INSTITUTES OF HEALTH NIAID","office_key":"o-75N930","first_action_date":"2025-04-22","last_action_date":"2026-07-10","actions":5,"obligated":"2805042.61","current_total_value":"26944786.61","potential_total_value":"33860136.61","naics":"541715","psc":"AN12","extent_competed":"FULL AND OPEN COMPETITION","set_aside":"NO SET ASIDE USED.","offers_received":12,"description":"TO SELECT A NOVEL SMALL MOLECULE ANTIBIOTIC FOR CLINICAL DEVELOPMENT AND ADVANCE IT THROUGH IND FILING AND PHASE 1 CLINICAL STUDIES.","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null}],"awards_total":2,"awards_page":1,"won":[],"won_total":0,"solicitations_won":[]}